Exogenous interleukin-10 fails to decrease the mortality or morbidity of sepsis
- 1 May 1998
- journal article
- research article
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 26 (5) , 895-904
- https://doi.org/10.1097/00003246-199805000-00025
Abstract
To determine if exogenous interleukin (IL)-10 will decrease the morbidity or mortality of sepsis induced by cecal ligation and puncture. Prospective, randomized, controlled study. University research laboratory. Adult, female, Balb/c mice. Balb/c mice were subjected to cecal ligation and puncture with an 18- or 23-gauge needle and treated with triple antibiotics. Mice were injected subcutaneously with recombinant human IL-10 (diluted in normal saline with 0.1% mouse serum albumin) and followed until death. In a separate experiment, IL-10 was also injected subcutaneously and lipopolysaccharide (LPS) injected intraperitoneally and plasma tumor necrosis factor concentrations measured 90 mins later. In the LPS experiments, IL-10 decreased tumor necrosis factor (TNF) production by nearly 90%. For the cecal ligation and puncture experiments, temperature and movement were recorded continuously via implanted transmitters. Studies on mortality indicated that exogenous IL-10 given at 0, +6 and +12 hrs after surgery failed to increase survival when using an 18-gauge needle (alive:total cecal ligation and puncture alone 4:21; IL-10 10 [micro sign]g/mouse 2:12; 1 [micro sign]g/mouse 8:25; 0.1 [micro sign]g/mouse 1:12) or a 23-gauge needle (cecal ligation and puncture alone 13:29; IL-10 1 [micro sign]g 18:30). There was no difference in the number of hours to death between the groups. IL-10 did not prevent the hypothermia after cecal ligation and puncture or increase the animals' activity. To examine parameters of inflammation, mice were killed 8 hrs after 18-gauge cecal ligation and puncture. IL-10 (1 [micro sign]g/mL) failed to reduce pulmonary neutrophil sequestration (lung myeloperoxidase, cecal ligation and puncture 107 +/- 10 [SEM], IL-10 107 +/- 5) or recruitment of neutrophils to the peritoneum (neutrophils x 106, cecal ligation and puncture 3.72 +/- 0.62; IL-10 3.49 +/- 0.37). IL-10 also failed to reduce the appearance of TNF or IL-6 in the plasma or peritoneal fluid. The chemokine KC was reduced in the peritoneal fluid but not the plasma and endogenous IL-10 production was not reduced in the peritoneum. Our data indicate that exogenous IL-10 fails to improve morbidity or mortality in the clinically relevant cecal ligation and puncture model of sepsis. (Crit Care Med 1998; 26:895-904)Keywords
This publication has 29 references indexed in Scilit:
- Sir Isaac Newton, sepsis, SIRS, and CARSCritical Care Medicine, 1996
- BLOCKADE OF TUMOR NECROSIS FACTOR REDUCES LIPOPOLYSACCHARIDE LETHALITY, BUT NOT THE LETHALITY OF CECAL LIGATION AND PUNCTUREShock, 1995
- Pathogenetic Mechanisms of Septic ShockNew England Journal of Medicine, 1993
- Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia.The Journal of Experimental Medicine, 1993
- Interleukin 10 inhibits macrophage microbicidal activity by blocking the endogenous production of tumor necrosis factor alpha required as a costimulatory factor for interferon gamma-induced activation.Proceedings of the National Academy of Sciences, 1992
- Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in SepsisChest, 1992
- Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes.The Journal of Experimental Medicine, 1991
- Wehi 164 Subclone 13 Assay for Tnf: Sensitivity, Specificity, and ReliabilityImmunological Investigations, 1989
- Involvement of Tumour Necrosis Factor and Other Cytokines in Immune-Mediated Vascular PathologyInternational Archives of Allergy and Immunology, 1988
- Production of hybridoma growth factor by human monocytesEuropean Journal of Immunology, 1987